rivastigmine has been researched along with Acute Post-Traumatic Stress Disorder in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Murray, A; Nielssen, O; Wallace, D | 1 |
| Fayyazi Bordbar, MR; Talaei, A | 1 |
| Fayyazi Bordbar, MR; Hosseini, G; Mostafavi Toroghi, H; Rezaei Ardani, A; Talaei, A | 1 |
1 trial(s) available for rivastigmine and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Effect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial.
Topics: Adult; Cholinesterase Inhibitors; Chronic Disease; Combat Disorders; Double-Blind Method; Drug Synergism; GABA Agents; Humans; Iran; Male; Middle Aged; Outcome Assessment, Health Care; Pilot Projects; Rivastigmine; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Valproic Acid | 2017 |
2 other study(ies) available for rivastigmine and Acute Post-Traumatic Stress Disorder
| Article | Year |
|---|---|
Rivastigmine for treatment resistant Post Traumatic stress disorder.
Topics: Arousal; Cholinesterase Inhibitors; Diagnostic and Statistical Manual of Mental Disorders; Disability Evaluation; Drug Resistance, Multiple; Humans; Memory; Psychiatric Status Rating Scales; Rivastigmine; Self-Assessment; Stress Disorders, Post-Traumatic; Treatment Outcome | 2017 |
Rivastigmine as an effective add-on to standard treatment of veterans with chronic posttraumatic stress disorder: a case series.
Topics: Checklist; Cholinesterase Inhibitors; Chronic Disease; Drug Therapy, Combination; Humans; Iran; Male; Middle Aged; Phenylcarbamates; Psychiatric Status Rating Scales; Remission Induction; Rivastigmine; Severity of Illness Index; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome; Veterans Health | 2013 |